Cheers @Gurmat2015,
We are too early into the business cycle to accurately predict outcomes as I don't have access to a full data analysis of the company structure at my finger tips. So based on that I can only answer this way.
1) Unknown but watch 4C's
2) The Hemple product has a live streaming order inquiry register. That is a known. You can tell how many people are buying (online retail) by watching that. Demand compare to peers? Unknown..missing data.
3) I try and avoid mentioning future share prices on HC (the scapegoat stigma). But if you use any successful business model based on good management, signed revenue deals, product to market, healthy supply chains and distribution structures, plus good company fundamentals, then we talk $ not c's for the sp. Time period: Market decides.
Cheers....59
- Forums
- ASX - By Stock
- CGB
- Current SP
Current SP, page-1277
-
- There are more pages in this discussion • 749 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online